These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 11936867

  • 1. In vitro-prepared advanced glycation end-products and the modulating potential of their low-molecular weight degradation products in IRPTC-A rat proximal-tubular derived kidney epithelial cell line.
    Deuther-Conrad W, Franke S, Henle T, Sommer M, Stein G.
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL187-96. PubMed ID: 11936867
    [Abstract] [Full Text] [Related]

  • 2. Differences in the modulating potential of advanced glycation end product (AGE) peptides versus AGE proteins.
    Deuther-Conrad W, Franke S, Sommer M, Henle T, Stein G.
    Kidney Int Suppl; 2001 Feb; 78():S63-6. PubMed ID: 11168985
    [Abstract] [Full Text] [Related]

  • 3. Advanced glycated albumin impairs protein degradation in the kidney proximal tubules cell line LLC-PK1.
    Sebeková K, Schinzel R, Ling H, Simm A, Xiang G, Gekle M, Münch G, Vamvakas S, Heidland A.
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1051-60. PubMed ID: 9846887
    [Abstract] [Full Text] [Related]

  • 4. Effects of advanced glycation end product modification on proximal tubule epithelial cell processing of albumin.
    Ozdemir AM, Hopfer U, Rosca MV, Fan XJ, Monnier VM, Weiss MF.
    Am J Nephrol; 2008 Nov; 28(1):14-24. PubMed ID: 17890854
    [Abstract] [Full Text] [Related]

  • 5. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
    Kim YS, Kim NH, Lee SW, Lee YM, Jang DS, Kim JS.
    Eur J Pharmacol; 2007 Aug 27; 569(3):171-9. PubMed ID: 17597607
    [Abstract] [Full Text] [Related]

  • 6. Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells.
    Yamagishi S, Inagaki Y, Okamoto T, Amano S, Koga K, Takeuchi M.
    Kidney Int; 2003 Feb 27; 63(2):464-73. PubMed ID: 12631112
    [Abstract] [Full Text] [Related]

  • 7. Processing advanced glycation end product-modified albumin by the renal proximal tubule and the early pathogenesis of diabetic nephropathy.
    Ozdemir AM, Hopfer U, Erhard P, Monnier VM, Weiss MF.
    Ann N Y Acad Sci; 2005 Jun 27; 1043():625-36. PubMed ID: 16037286
    [Abstract] [Full Text] [Related]

  • 8. Advanced glycation end products inhibit tubulogenesis and migration of kidney epithelial cells in an ezrin-dependent manner.
    Gallicchio MA, McRobert EA, Tikoo A, Cooper ME, Bach LA.
    J Am Soc Nephrol; 2006 Feb 27; 17(2):414-21. PubMed ID: 16371434
    [Abstract] [Full Text] [Related]

  • 9. Advanced glycation end-products induce calpain-mediated degradation of ezrin.
    McRobert EA, Young AN, Bach LA.
    FEBS J; 2012 Sep 27; 279(17):3240-50. PubMed ID: 22805611
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
    Zhang FL, Gao HQ, Shen L.
    J Cardiovasc Pharmacol; 2007 Oct 27; 50(4):434-40. PubMed ID: 18049312
    [Abstract] [Full Text] [Related]

  • 11. Uptake of advanced glycation end products by proximal tubule epithelial cells via macropinocytosis.
    Gallicchio MA, Bach LA.
    Biochim Biophys Acta; 2013 Dec 27; 1833(12):2922-2932. PubMed ID: 23747564
    [Abstract] [Full Text] [Related]

  • 12. Significance of proximal tubular metabolism of advanced glycation end products in kidney diseases.
    Saito A, Takeda T, Sato K, Hama H, Tanuma A, Kaseda R, Suzuki Y, Gejyo F.
    Ann N Y Acad Sci; 2005 Jun 27; 1043():637-43. PubMed ID: 16037287
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of regucalcin suppresses cell response for tumor necrosis factor-alpha or transforming growth factor-beta1 in cloned normal rat kidney proximal tubular epithelial NRK52E cells.
    Nakagawa T, Yamaguchi M.
    J Cell Biochem; 2007 Apr 01; 100(5):1178-90. PubMed ID: 17063480
    [Abstract] [Full Text] [Related]

  • 14. Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages.
    Pertyńska-Marczewska M, Kiriakidis S, Wait R, Beech J, Feldmann M, Paleolog EM.
    Cytokine; 2004 Oct 07; 28(1):35-47. PubMed ID: 15341924
    [Abstract] [Full Text] [Related]

  • 15. Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy.
    Chibber R, Molinatti PA, Rosatto N, Lambourne B, Kohner EM.
    Diabetologia; 1997 Feb 07; 40(2):156-64. PubMed ID: 9049475
    [Abstract] [Full Text] [Related]

  • 16. Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions.
    Kowluru RA.
    Life Sci; 2005 Jan 14; 76(9):1051-60. PubMed ID: 15607333
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells.
    Stitt AW, He C, Vlassara H.
    Biochem Biophys Res Commun; 1999 Mar 24; 256(3):549-56. PubMed ID: 10080935
    [Abstract] [Full Text] [Related]

  • 18. Association of advanced glycation end products with A549 cells, a human pulmonary epithelial cell line, is mediated by a receptor distinct from the scavenger receptor family and RAGE.
    Nakano N, Fukuhara-Takaki K, Jono T, Nakajou K, Eto N, Horiuchi S, Takeya M, Nagai R.
    J Biochem; 2006 May 24; 139(5):821-9. PubMed ID: 16751589
    [Abstract] [Full Text] [Related]

  • 19. Advanced glycation end product (AGE): characterization of the products from the reaction between D-glucose and serum albumin.
    Wu JT, Tu MC, Zhung P.
    J Clin Lab Anal; 1996 May 24; 10(1):21-34. PubMed ID: 8926563
    [Abstract] [Full Text] [Related]

  • 20. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE).
    Oldfield MD, Bach LA, Forbes JM, Nikolic-Paterson D, McRobert A, Thallas V, Atkins RC, Osicka T, Jerums G, Cooper ME.
    J Clin Invest; 2001 Dec 24; 108(12):1853-63. PubMed ID: 11748269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.